Showing results (141-150 of 175) with videos related to
Sort By:
Pageof 18
Gynecologic Oncology|November 7, 2000
Chemotherapy for malignant mixed Müllerian tumors of the ovaryA S Sit, F V Price, J L Kelley, et al.Cancer|October 1, 1991
Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinomaA H Frank, P C Tseng, B G Haffty, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
FRA-1 expression in hyperplastic and neoplastic thyroid diseasesG Chiappetta, G Tallini, M C De Biasio, et al.Pathologica|November 24, 2015
Pathological spectrum in recurrences of glioblastoma multiformeG Marucci, P V Fabbri, L Morandi, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 16, 2017
Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective studyG Martelli, R Miceli, S Folli, et al.British Journal of Cancer|December 4, 2003
Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among womenL M Morton, T R Holford, B Leaderer, et al.American Journal of Clinical Pathology|April 13, 2000
Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptorE Diaz de Leon, M L Carcangiu, V G Prieto, et al.British Journal of Cancer|March 14, 2007
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)E Franceschi, G Cavallo, S Lonardi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2009
Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumoursA Perotti, C Sessa, A Mancuso, et al.Annales De Pathologie|October 31, 2001
[Spindle cell lipoma and 13q deletion: diagnostic utility of cytogenetic analysis]J M Dumollard, D Ranchère-Vince, F Burel, et al.Pageof 18